TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 28 filers reported holding TALIS BIOMEDICAL CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,073,176 | -2.0% | 2,235,783 | 0.0% | 0.05% | -16.7% |
Q1 2023 | $1,095,534 | +9.9% | 2,235,783 | 0.0% | 0.06% | -13.0% |
Q4 2022 | $996,488 | -34.6% | 2,235,783 | 0.0% | 0.07% | -36.1% |
Q3 2022 | $1,524,000 | -16.1% | 2,235,783 | 0.0% | 0.11% | -23.4% |
Q2 2022 | $1,816,000 | -42.4% | 2,235,783 | 0.0% | 0.14% | -29.5% |
Q1 2022 | $3,152,000 | -49.9% | 2,235,783 | +42.5% | 0.20% | -44.4% |
Q4 2021 | $6,293,000 | – | 1,569,300 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nicholas Investment Partners, LP | 1,101,401 | $14,153,000 | 0.99% |
Boxer Capital, LLC | 1,550,998 | $19,930,000 | 0.68% |
ArrowMark Colorado Holdings LLC | 6,001,971 | $77,125,000 | 0.58% |
Baker Brothers Advisors | 7,574,835 | $97,337,000 | 0.42% |
SECTORAL ASSET MANAGEMENT INC | 405,094 | $5,205,000 | 0.40% |
Redmile Group, LLC | 400,000 | $5,140,000 | 0.07% |
Perceptive Advisors | 250,000 | $3,212,000 | 0.04% |
FEDERATED HERMES, INC. | 1,030,000 | $13,236,000 | 0.03% |
Alyeska Investment Group, L.P. | 50,000 | $643,000 | 0.01% |
CAAS CAPITAL MANAGEMENT LP | 40,000 | $514,000 | 0.01% |